van Vlerken LE - Search Results

1

Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model.

van Vlerken LE, Duan Z, Little SR, Seiden MV, Amiji MM. van Vlerken LE, et al. Mol Pharm. 2008 Jul-Aug;5(4):516-26. doi: 10.1021/mp800030k. Epub 2008 Jul 11. Mol Pharm. 2008. PMID: 18616278 Free PMC article.

2

Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.

van Vlerken LE, Duan Z, Seiden MV, Amiji MM. van Vlerken LE, et al. Cancer Res. 2007 May 15;67(10):4843-50. doi: 10.1158/0008-5472.CAN-06-1648. Cancer Res. 2007. PMID: 17510414

3

Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.

Yadav S, van Vlerken LE, Little SR, Amiji MM. Yadav S, et al. Among authors: van vlerken le. Cancer Chemother Pharmacol. 2009 Mar;63(4):711-22. doi: 10.1007/s00280-008-0790-y. Epub 2008 Jul 11. Cancer Chemother Pharmacol. 2009. PMID: 18618115

4

Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems.

van Vlerken LE, Duan Z, Little SR, Seiden MV, Amiji MM. van Vlerken LE, et al. AAPS J. 2010 Jun;12(2):171-80. doi: 10.1208/s12248-010-9174-4. Epub 2010 Feb 9. AAPS J. 2010. PMID: 20143195 Free PMC article.

5

Multi-functional nanocarriers for targeted delivery of drugs and genes.

Jabr-Milane L, van Vlerken L, Devalapally H, Shenoy D, Komareddy S, Bhavsar M, Amiji M. Jabr-Milane L, et al. J Control Release. 2008 Sep 10;130(2):121-8. doi: 10.1016/j.jconrel.2008.04.016. Epub 2008 Apr 29. J Control Release. 2008. PMID: 18538887 Review.

6

Multi-functional polymeric nanoparticles for tumour-targeted drug delivery.

van Vlerken LE, Amiji MM. van Vlerken LE, et al. Expert Opin Drug Deliv. 2006 Mar;3(2):205-16. doi: 10.1517/17425247.3.2.205. Expert Opin Drug Deliv. 2006. PMID: 16506948 Review.

7

Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.

van Vlerken LE, Vyas TK, Amiji MM. van Vlerken LE, et al. Pharm Res. 2007 Aug;24(8):1405-14. doi: 10.1007/s11095-007-9284-6. Epub 2007 Mar 29. Pharm Res. 2007. PMID: 17393074 Review.

8

Multi-functional nanocarriers to overcome tumor drug resistance.

Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM. Jabr-Milane LS, et al. Among authors: van vlerken le. Cancer Treat Rev. 2008 Nov;34(7):592-602. doi: 10.1016/j.ctrv.2008.04.003. Epub 2008 Jun 5. Cancer Treat Rev. 2008. PMID: 18538481 Free PMC article. Review.

9

Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis.

Benou C, Wang Y, Imitola J, VanVlerken L, Chandras C, Karalis KP, Khoury SJ. Benou C, et al. J Immunol. 2005 May 1;174(9):5407-13. doi: 10.4049/jimmunol.174.9.5407. J Immunol. 2005. PMID: 15843539

10

NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene.

Karalis KP, Venihaki M, Zhao J, van Vlerken LE, Chandras C. Karalis KP, et al. Among authors: van vlerken le. J Biol Chem. 2004 Mar 19;279(12):10837-40. doi: 10.1074/jbc.M313063200. Epub 2004 Jan 6. J Biol Chem. 2004. PMID: 14711817 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page